Predicting Response to rhDNase and Hypertonic Saline in Children with Cystic Fibrosis

Pediatric Pulmonology

Volumn 37, Issue 4, 2004, Pages 305-310

  Suri, Ranjan ^a,b   Metcalfe, Christopher ^c   Wallis, Colin ^b   Bush, Andrew ^a,d  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c MRC BIOSTATISTICS UNIT   (United Kingdom)

^d ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cystic fibrosis; Hypertonic saline; RhDNase

Indexed keywords

DNA; DORNASE ALFA; SODIUM CHLORIDE;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYSTIC FIBROSIS; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFICACY; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; OPEN STUDY; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SPIROMETRY;

ADOLESCENT; CHILD; CROSS-OVER STUDIES; CYSTIC FIBROSIS; DEOXYRIBONUCLEASE I; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; NEBULIZERS AND VAPORIZERS; PREDICTIVE VALUE OF TESTS; RECOMBINANT PROTEINS; SALINE SOLUTION, HYPERTONIC; VITAL CAPACITY;

EID: 1942506015     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.10442     Document Type: Article

References (17)

1. FitzSimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr 1993;122:1-9.
2. Chernick WS, Barbero GJ. Composition of tracheobronchial secretions in cystic fibrosis of the pancreas and bronchiectasis. Pediatrics 1959;24:739-745.
3. Ramsey BW, Astley SJ, Aitken ML, Burke W, Colin AA, Dorkin HL, Eisenberg JD, Gibson RL, Harwood IR, Schidlow DV, et al. Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis. Am Rev Respir Dis 1993;148:145-151.
4. Ranasinha C, Assoufi B, Shak S, Christiansen DH, Fuchs H, Empey D, Geddes D, Hodson ME. Efficacy and safety of short-term administration of aerosolised recombinant human DNase 1 in adults with stable stage cystic fibrosis. Lancet 1993; 342:199-202.
5. Fuchs H, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, Rosenstein BJ, Smith A, Wohl ME. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. N Engl J Med 1994;331:637-642.
6. British Medical Association and Royal Pharmaceutical Society of Great Britain. British national formulary 41. London: BMJ Books; 2001.
7. Davies J, Trindale MT, Wallis C, Rosenthal M, Crawford O, Bush A. Retrospective review of the effects of rhDNase in children with cystic fibrosis. Pediatr Pulmonol 1997;23:243-248.
8. Wojnarowski C, Eichler J, Frischer T, Storm K, Renner S, Gotz M. RhDNase therapy in patients with CF: is it possible to predict lung function improvement? Pediatr Pulmonol [Suppl] 1995; 12:237.
9. Bollert FGE, Paton JY, Marshall TG, Calvert J, Greening AP, Innes JA. Recombinant DNase in cystic fibrosis: a protocol for targeted introduction through n-of-1 trials. Eur Respir J 1999; 13:107-113.
10. Suri R, Metcalfe C, Lees B, Grieve R, Flather M, Normand C, Thompson S, Bush A, Wallis C. Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial. Lancet 2001; 358:1316-1321.
11. Robinson M, Regnis JA, Bailey DL, King M, Bautovich GJ, Bye PT. Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis. Am J Respir Crit Care Med 1996;153:1503-1509.
12. Robinson M, Hemming AL, Regnis JA, Wong AG, Bailey DL, Bautovich GJ, King M, Bye PT. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Thorax 1997;52:900-903.
13. Riedler J, Reade T, Button B, Robertson CF. Inhaled hypertonic saline increases sputum expectoration in cystic fibrosis. J Paediatr Child Health 1996;32:48-50.
14. Eng PA, Morton J, Douglass JA, Riedler J, Wilson J, Robertson CF. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis. Pediatr Pulmonol 1996;21:77-83.
15. Polgar G, Promodhat V. Pulmonary function testing in children: techniques and standards. Philadelphia: W.B. Saunders Co.; 1971.
16. Ballmann M, von der Hardt H. Hypertonic saline and recombinant human DNase: a randomized cross-over pilot study in patients with cystic fibrosis. Pediatr Pulmonol [Suppl] 1998;17:343.
17. American Thoracic Society. Standardization of spirometry. Am J Respir Crit Care Med 1994;152:1107-1136.